Systemic Lupus Erythematosus clinical trial
Dec 18, 2017
Systemic Lupus Erythematosus (SLE) – Market Is Expected to Grow with Upcoming Therapies
Systemic Lupus Erythematosus (SLE) is a chronic, multisystem, inflammatory autoimmune disease which leads to weakening of the immune system. It results in systemic inflammation which affects multiple organs such as kidneys, the tissue lining the lungs (pleura), heart (pericardium), and brain. Acute Cutaneous Lupus, ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
